PL369581A1 - Stabilizowane miejscowe preparaty brywudyny - Google Patents

Stabilizowane miejscowe preparaty brywudyny

Info

Publication number
PL369581A1
PL369581A1 PL02369581A PL36958102A PL369581A1 PL 369581 A1 PL369581 A1 PL 369581A1 PL 02369581 A PL02369581 A PL 02369581A PL 36958102 A PL36958102 A PL 36958102A PL 369581 A1 PL369581 A1 PL 369581A1
Authority
PL
Poland
Prior art keywords
stabilized
topical formulations
brivudine
brivudine topical
formulations
Prior art date
Application number
PL02369581A
Other languages
English (en)
Inventor
Christian Schnittker
Sigrid Keipert
Karsten Gröger
Reinhard Schmitz
Carlo Alberto Maggi
Stefano Manzini
Original Assignee
Menarini Ricerche S.P.A.
Berlin-Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche S.P.A., Berlin-Chemie Ag filed Critical Menarini Ricerche S.P.A.
Publication of PL369581A1 publication Critical patent/PL369581A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Devices For Dispensing Beverages (AREA)
  • Filling Of Jars Or Cans And Processes For Cleaning And Sealing Jars (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02369581A 2001-12-19 2002-12-04 Stabilizowane miejscowe preparaty brywudyny PL369581A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10162593A DE10162593A1 (de) 2001-12-19 2001-12-19 Stabilisierte topische Brivudin-Formulierungen

Publications (1)

Publication Number Publication Date
PL369581A1 true PL369581A1 (pl) 2005-05-02

Family

ID=7709921

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02369581A PL369581A1 (pl) 2001-12-19 2002-12-04 Stabilizowane miejscowe preparaty brywudyny

Country Status (15)

Country Link
US (1) US20040259835A1 (pl)
EP (1) EP1463513B1 (pl)
JP (1) JP2005516929A (pl)
CN (1) CN1316977C (pl)
AR (1) AR038455A1 (pl)
AU (1) AU2002366273A1 (pl)
CA (1) CA2470629A1 (pl)
DE (2) DE10162593A1 (pl)
ES (1) ES2280625T3 (pl)
PA (1) PA8562001A1 (pl)
PE (1) PE20030696A1 (pl)
PL (1) PL369581A1 (pl)
RU (1) RU2306935C2 (pl)
UY (1) UY27591A1 (pl)
WO (1) WO2003051375A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
WO2005065630A1 (ja) * 2004-01-06 2005-07-21 Shiseido Co., Ltd. 一相マイクロエマルション組成物、o/w超微細エマルション外用剤、及びその製造方法
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
PT1962808E (pt) * 2005-12-14 2010-10-29 Hoffmann La Roche Formulação de precursor de fármaco para o hcv
KR20090057440A (ko) * 2006-09-15 2009-06-05 아스텔라스세이야쿠 가부시키가이샤 빛에 대하여 안정한 라모세트론의 고형 의약 조성물
US20100323998A1 (en) * 2007-08-06 2010-12-23 Glenmark Pharmaceuticals Ltd. Topical composition containing the combination of mupirocin and beclomethasone
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
SG175327A1 (en) * 2009-04-22 2011-11-28 Agency Science Tech & Res Emulsions for transdermal delivery
CN102548538B (zh) * 2009-09-22 2014-03-12 V生命科学技术有限公司 治疗糖尿病足溃疡的局部制剂
EP2490722A4 (en) * 2009-10-21 2014-03-05 Otonomy Inc MODULATION OF THE TEMPERATURE OF GELIFICATION OF FORMULATIONS CONTAINING POLOXAMERS
US8835643B2 (en) 2012-02-23 2014-09-16 Empire Technology Development Llc Molecules, compositions, and methods for light absorption
JP2016534121A (ja) 2013-08-27 2016-11-04 オトノミ—,インク. 小児の耳の病気の処置
CN106138018B (zh) * 2015-04-02 2020-03-13 广州洁成生物科技有限公司 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用
BR112019003319B8 (pt) * 2016-08-31 2023-01-24 Chr Hansen Natural Colors As Composições de coloração dispersíveis em água, seu uso, seu método de preparação e produto comestível
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
RU2133120C1 (ru) * 1995-12-14 1999-07-20 Сантр Энтернасьональ де Решерш Дерматоложик Галдерма Косметическая или дерматологическая композиция типа эмульсии вода-в-масле
CZ284920B6 (cs) * 1996-02-14 1999-04-14 Vladimír Prof. Mudr. Drsc. Vonka Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem
GB9618974D0 (en) * 1996-09-11 1996-10-23 Glaxo Group Ltd Medicaments
DE19956601A1 (de) * 1999-11-25 2001-05-31 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
CN1316977C (zh) 2007-05-23
CA2470629A1 (en) 2003-06-26
UY27591A1 (es) 2003-02-28
AR038455A1 (es) 2005-01-19
AU2002366273A1 (en) 2003-06-30
JP2005516929A (ja) 2005-06-09
DE60218346D1 (de) 2007-04-05
RU2004118426A (ru) 2005-04-20
RU2306935C2 (ru) 2007-09-27
CN1604782A (zh) 2005-04-06
DE60218346T2 (de) 2007-11-08
EP1463513A1 (en) 2004-10-06
PA8562001A1 (es) 2003-07-28
EP1463513B1 (en) 2007-02-21
WO2003051375A1 (en) 2003-06-26
ES2280625T3 (es) 2007-09-16
PE20030696A1 (es) 2003-09-22
US20040259835A1 (en) 2004-12-23
DE10162593A1 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
GB0108082D0 (en) Topical composition
GC0000397A (en) Olopatadine formulations for topical administration
HUP0300768A3 (en) Pesticidal formulations
AU7860201A (en) Dermatological composition
GB0126144D0 (en) Pesticidal formulations
PL369581A1 (pl) Stabilizowane miejscowe preparaty brywudyny
SI1513514T1 (sl) Topične formulacije hidroksimatairezinola
GB0106601D0 (en) Antiperspirant formulations
GB0015490D0 (en) Novel formulations
GB0116945D0 (en) Antiperspirant formulations
EP1370240A4 (en) NEUROPROTECTOR FORMULATIONS AND METHOD
GB0116946D0 (en) Antiperspirant formulations
HUP0600300A2 (en) Ribavirin syrup formulations
EP1350522A4 (en) TOPICAL ANESTHESIA COMPOSITIONS
GB0111314D0 (en) Dermatological formulations
PL365741A1 (pl) Stabilizowane preparaty briwudyny przeznaczone dostosowania miejscowego
GB0110681D0 (en) Antiperspirant formulations
GB0115893D0 (en) Formulations
GB2374107B (en) Channel sections
EG22944A (en) Systemic formulations
NZ513664A (en) Long acting formulations
GB0107226D0 (en) Formulations
TJ20010680A (en) Ointment tiomekol
HU0105389D0 (en) Topical composition
GB0104439D0 (en) Topical composition

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)